Vir Biotechnology Inc
Change company Symbol lookup
Select an option...
VIR Vir Biotechnology Inc
$NQUSB40401010N Nasdaq US Benchmark Diversified Reta
IVZ Invesco Ltd
SPLK Splunk Inc
TW Tradeweb Markets Inc
CMPGY Compass Group PLC
DZSI DZS Inc
FCPT Four Corners Property Trust Inc
UGI UGI Corp
BMI Badger Meter Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Vir Biotechnology, Inc. is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. It has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The Company's pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus (HBV), influenza A virus, and human immunodeficiency virus (HIV). Its product candidates include Sotrovimab and VIR-7832, VIR-2218, VIR-3434, VIR-2482, VIR-1111. It is engaged in developing differentiated monoclonal antibodies (mAbs) as well as vaccines and small molecules that focuses is on treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VIR-2218 and VIR-3434, are for the treatment of HBV. VIR-2482 is an investigational IM administered influenza A-neutralizing mAb.

Postmarket

Last Trade
Delayed
$29.97
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

-0.17 (-0.56%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$30.14
Day's Change
0.23 (0.77%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
30.95
Day's Low
29.35
Volume
(Average)
Volume:
859,517

10-day average volume:
895,288
859,517
Historical quotes & splits

Take-Two Interactive Software Inc. Stock Rises Thursday, Still Underperforms Market

5:26 pm ET November 10, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Take-Two Interactive Software Inc. (TTWO) rose 4.76% to $98.57 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 5.54% to 3,956.37 and the Dow Jones Industrial Average rising 3.70% to 33,715.37. This was the stock's second consecutive day of gains. Take-Two Interactive Software Inc. closed $90.94 below its 52-week high ($189.51), which the company achieved on November 12th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Microsoft Corp. (MSFT) rose 8.23% to $242.98, Sony Group Corp. ADR (6758.TO) rose 6.65% to $80.50, and Activision Blizzard Inc. (ATVI) rose 2.74% to $73.62. Trading volume (3.1 M) eclipsed its 50-day average volume of 2.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 10, 2022.

(END) Dow Jones Newswires

November 10, 2022 17:26 ET (22:26 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure